Cellectar Biosciences Inc. (CLRB) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Cellectar Biosciences Inc...

NASDAQ: CLRB · Real-Time Price · USD
5.69
-0.11 (-1.90%)
At close: Oct 03, 2025, 3:59 PM
5.78
1.58%
After-hours: Oct 03, 2025, 05:54 PM EDT

Cellectar Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-5.45M -6.6M -2.36M -14.66M -919.37K -26.64M -7.45M -17.52M -10.18M -7.19M -7.22M -7.81M -7.44M -6.14M -5.92M -5.82M -6.03M -6.36M
Depreciation & Amortization
55.56K 56.3K 68.57K 68.57K 66.02K 88.49K 69.96K 41.21K 38.65K 42.56K 38.16K 32.96K 33.9K 43.42K 39.29K 36.79K 38.7K 35.13K
Stock-Based Compensation
565.39K 562.74K 1.49M 1.53M 799.25K 454.36K 1.08M 497.88K 419.76K 408.21K 361.45K 367.76K 419.95K 303.81K 377.85K 421.16K 200.62K 124.56K
Other Working Capital
176.4K -3.74M -63.56K 2.22M -1.66M -2.22M 1.58M 740.64K 205.06K 946.83K -620.16K 374.41K 1.2M 731.43K 969.39K -1.09M -1.11M 1.42M
Other Non-Cash Items
-464.97K 340K -10.05M 1.67M -12.42M 14.96M -4.88M 8.17M 1.99M -1.39M 23.89K 23.01K 25.56K 21.36K 20.56K 19.79K 19.05K 21.26K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
176.4K -3.74M -63.56K 2.22M -1.66M -2.22M 1.58M 740.64K 205.06K 946.83K -620.16K 374.41K 1.2M 731.43K 969.39K -1.09M -1.11M 1.42M
Operating Cash Flow
-5.12M -9.38M -10.91M -9.17M -14.14M -13.36M -9.6M -8.07M -7.53M -7.18M -7.41M -7.01M -5.76M -5.04M -4.51M -6.43M -6.88M -4.75M
Capital Expenditures
n/a n/a -61.29K n/a -21.28K -21.63K -266.76K -597.28K n/a n/a -117.86K -7.07K -70.98K -30.07K -129.74K -4.06K -7.56K n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a -61.29K n/a -21.28K -21.63K -266.76K -597.28K n/a n/a -117.86K -7.07K -70.98K -30.07K -129.74K -4.06K -7.56K n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.25M n/a n/a 17.56M n/a 43.85M 441K 22.5M n/a 3.00 n/a n/a n/a n/a n/a n/a 34.87K 1.21M
Financial Cash Flow
2.25M n/a n/a 17.56M n/a 43.85M 441K 22.5M n/a 3.00 9.61M n/a n/a n/a n/a n/a 34.87K 1.21M
Net Cash Flow
-2.86M -9.38M -10.97M 8.39M -14.16M 30.47M -9.42M 13.83M -7.53M -7.18M 2.08M -7.02M -5.83M -5.07M -4.64M -6.43M -6.85M -3.54M
Free Cash Flow
-5.12M -9.38M -10.97M -9.17M -14.16M -13.38M -9.86M -8.67M -7.53M -7.18M -7.53M -7.02M -5.83M -5.07M -4.64M -6.43M -6.88M -4.75M